世界の超免疫グロブリン市場:メーカー別、地域別、種類別、用途別、市場予測

GlobalInfoResearchが発行した調査報告書(GIR805237)
◆英語タイトル:Global Hyperimmune Globulins Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
◆商品コード:GIR805237
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2018年5月
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥393,240見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD4,680 ⇒換算¥528,840見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、超免疫グロブリンの世界市場について調査・分析し、超免疫グロブリンの世界市場概観、メーカー動向、メーカー別超免疫グロブリンシェア、市場規模推移、市場規模予測、超免疫グロブリン種類別分析(型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他)、超免疫グロブリン用途別分析(政府機関、民間部門、その他民間部門、その他)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・超免疫グロブリンの市場概観
・超免疫グロブリンのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・超免疫グロブリンのメーカー別販売動向、市場シェア、市場集中度、競争動向
・超免疫グロブリンの世界市場規模
・超免疫グロブリンの北米市場分析(アメリカ、カナダ、メキシコ等)
・超免疫グロブリンのアメリカ市場規模推移
・超免疫グロブリンのカナダ市場規模推移
・超免疫グロブリンのメキシコ市場規模推移
・超免疫グロブリンのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・超免疫グロブリンのドイツ市場規模推移
・超免疫グロブリンのイギリス市場規模推移
・超免疫グロブリンのロシア市場規模推移
・超免疫グロブリンのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・超免疫グロブリンの日本市場規模推移
・超免疫グロブリンの中国市場規模推移
・超免疫グロブリンの韓国市場規模推移
・超免疫グロブリンのインド市場規模推移
・超免疫グロブリンの東南アジア市場規模推移
・超免疫グロブリンの南米・中東・アフリカ市場分析
・超免疫グロブリンの種類別分析/市場規模推移(型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他)
・超免疫グロブリンの用途別分析/市場規模推移(政府機関、民間部門、その他民間部門、その他)
・超免疫グロブリンの市場予測(地域別予測、種類別予測、用途別予測)
・超免疫グロブリンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides “passive” immunity to the patient against an agent. This is in contrast to vaccines that provide “active” immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant “passive” short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Scope of the Report:
This report focuses on the Hyperimmune Globulins in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others

Market Segment by Applications, can be divided into
Government Institutions
Private Sector
Other

There are 15 Chapters to deeply display the global Hyperimmune Globulins market.

Chapter 1, to describe Hyperimmune Globulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hyperimmune Globulins, with sales, revenue, and price of Hyperimmune Globulins, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyperimmune Globulins, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hyperimmune Globulins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hyperimmune Globulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents
1 Market Overview
1.1 Hyperimmune Globulins Introduction
1.2 Market Analysis by Type
1.2.1 Hepatitis B Immunoglobulins
1.2.2 Rabies Immunoglobulins
1.2.3 Tetanus Immunoglobulins
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Government Institutions
1.3.2 Private Sector
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 Business Overview
2.1.2 Hyperimmune Globulins Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Hyperimmune Globulins Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biotest
2.3.1 Business Overview
2.3.2 Hyperimmune Globulins Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Kedrion
2.4.1 Business Overview
2.4.2 Hyperimmune Globulins Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 CBPO
2.5.1 Business Overview
2.5.2 Hyperimmune Globulins Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Emergent (Cangene)
2.6.1 Business Overview
2.6.2 Hyperimmune Globulins Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Kamada
2.7.1 Business Overview
2.7.2 Hyperimmune Globulins Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 CNBG
2.8.1 Business Overview
2.8.2 Hyperimmune Globulins Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hualan Bio
2.9.1 Business Overview
2.9.2 Hyperimmune Globulins Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shanghai RAAS
2.10.1 Business Overview
2.10.2 Hyperimmune Globulins Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sichuan Yuanda Shuyang
2.11.1 Business Overview
2.11.2 Hyperimmune Globulins Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 ADMA Biologics
2.12.1 Business Overview
2.12.2 Hyperimmune Globulins Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hyperimmune Globulins Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Hyperimmune Globulins Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hyperimmune Globulins Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hyperimmune Globulins Manufacturer Market Share
3.3.2 Top 6 Hyperimmune Globulins Manufacturer Market Share
3.4 Market Competition Trend
4 Global Hyperimmune Globulins Market Analysis by Regions
4.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Regions
4.1.1 Global Hyperimmune Globulins Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hyperimmune Globulins Revenue and Market Share by Regions (2013-2018)
4.2 North America Hyperimmune Globulins Sales and Growth Rate (2013-2018)
4.3 Europe Hyperimmune Globulins Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hyperimmune Globulins Sales and Growth Rate (2013-2018)
4.5 South America Hyperimmune Globulins Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (2013-2018)
5 North America Hyperimmune Globulins by Countries
5.1 North America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
5.1.1 North America Hyperimmune Globulins Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hyperimmune Globulins Revenue and Market Share by Countries (2013-2018)
5.2 United States Hyperimmune Globulins Sales and Growth Rate (2013-2018)
5.3 Canada Hyperimmune Globulins Sales and Growth Rate (2013-2018)
5.4 Mexico Hyperimmune Globulins Sales and Growth Rate (2013-2018)
6 Europe Hyperimmune Globulins by Countries
6.1 Europe Hyperimmune Globulins Sales, Revenue and Market Share by Countries
6.1.1 Europe Hyperimmune Globulins Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hyperimmune Globulins Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hyperimmune Globulins Sales and Growth Rate (2013-2018)
6.3 UK Hyperimmune Globulins Sales and Growth Rate (2013-2018)
6.4 France Hyperimmune Globulins Sales and Growth Rate (2013-2018)
6.5 Russia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
6.6 Italy Hyperimmune Globulins Sales and Growth Rate (2013-2018)
7 Asia-Pacific Hyperimmune Globulins by Countries
7.1 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hyperimmune Globulins Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hyperimmune Globulins Revenue and Market Share by Countries (2013-2018)
7.2 China Hyperimmune Globulins Sales and Growth Rate (2013-2018)
7.3 Japan Hyperimmune Globulins Sales and Growth Rate (2013-2018)
7.4 Korea Hyperimmune Globulins Sales and Growth Rate (2013-2018)
7.5 India Hyperimmune Globulins Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
8 South America Hyperimmune Globulins by Countries
8.1 South America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
8.1.1 South America Hyperimmune Globulins Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hyperimmune Globulins Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hyperimmune Globulins Sales and Growth Rate (2013-2018)
8.3 Argentina Hyperimmune Globulins Sales and Growth Rate (2013-2018)
8.4 Colombia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
9 Middle East and Africa Hyperimmune Globulins by Countries
9.1 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hyperimmune Globulins Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hyperimmune Globulins Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
9.3 UAE Hyperimmune Globulins Sales and Growth Rate (2013-2018)
9.4 Egypt Hyperimmune Globulins Sales and Growth Rate (2013-2018)
9.5 Nigeria Hyperimmune Globulins Sales and Growth Rate (2013-2018)
9.6 South Africa Hyperimmune Globulins Sales and Growth Rate (2013-2018)
10 Global Hyperimmune Globulins Market Segment by Type
10.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hyperimmune Globulins Sales and Market Share by Type (2013-2018)
10.1.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2013-2018)
10.2 Hepatitis B Immunoglobulins Sales Growth and Price
10.2.1 Global Hepatitis B Immunoglobulins Sales Growth (2013-2018)
10.2.2 Global Hepatitis B Immunoglobulins Price (2013-2018)
10.3 Rabies Immunoglobulins Sales Growth and Price
10.3.1 Global Rabies Immunoglobulins Sales Growth (2013-2018)
10.3.2 Global Rabies Immunoglobulins Price (2013-2018)
10.4 Tetanus Immunoglobulins Sales Growth and Price
10.4.1 Global Tetanus Immunoglobulins Sales Growth (2013-2018)
10.4.2 Global Tetanus Immunoglobulins Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Hyperimmune Globulins Market Segment by Application
11.1 Global Hyperimmune Globulins Sales Market Share by Application (2013-2018)
11.2 Government Institutions Sales Growth (2013-2018)
11.3 Private Sector Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Hyperimmune Globulins Market Forecast (2018-2023)
12.1 Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2018-2023)
12.2 Hyperimmune Globulins Market Forecast by Regions (2018-2023)
12.2.1 North America Hyperimmune Globulins Market Forecast (2018-2023)
12.2.2 Europe Hyperimmune Globulins Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hyperimmune Globulins Market Forecast (2018-2023)
12.2.4 South America Hyperimmune Globulins Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hyperimmune Globulins Market Forecast (2018-2023)
12.3 Hyperimmune Globulins Market Forecast by Type (2018-2023)
12.3.1 Global Hyperimmune Globulins Sales Forecast by Type (2018-2023)
12.3.2 Global Hyperimmune Globulins Market Share Forecast by Type (2018-2023)
12.4 Hyperimmune Globulins Market Forecast by Application (2018-2023)
12.4.1 Global Hyperimmune Globulins Sales Forecast by Application (2018-2023)
12.4.2 Global Hyperimmune Globulins Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures
Figure Hyperimmune Globulins Picture
Table Product Specifications of Hyperimmune Globulins
Figure Global Sales Market Share of Hyperimmune Globulins by Types in 2017
Table Hyperimmune Globulins Types for Major Manufacturers
Figure Hepatitis B Immunoglobulins Picture
Figure Rabies Immunoglobulins Picture
Figure Tetanus Immunoglobulins Picture
Figure Others Picture
Figure Hyperimmune Globulins Sales Market Share by Applications in 2017
Figure Government Institutions Picture
Figure Private Sector Picture
Figure Other Picture
Figure United States Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure France Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure China Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure India Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Hyperimmune Globulins Type and Applications
Table CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Hyperimmune Globulins Type and Applications
Table Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Hyperimmune Globulins Type and Applications
Table Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Hyperimmune Globulins Type and Applications
Table Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CBPO Basic Information, Manufacturing Base and Competitors
Table CBPO Hyperimmune Globulins Type and Applications
Table CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
Table Emergent (Cangene) Hyperimmune Globulins Type and Applications
Table Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kamada Basic Information, Manufacturing Base and Competitors
Table Kamada Hyperimmune Globulins Type and Applications
Table Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CNBG Basic Information, Manufacturing Base and Competitors
Table CNBG Hyperimmune Globulins Type and Applications
Table CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Hyperimmune Globulins Type and Applications
Table Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table Shanghai RAAS Hyperimmune Globulins Type and Applications
Table Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table Sichuan Yuanda Shuyang Hyperimmune Globulins Type and Applications
Table Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table ADMA Biologics Hyperimmune Globulins Type and Applications
Table ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hyperimmune Globulins Sales by Manufacturer (2016-2017)
Figure Global Hyperimmune Globulins Sales Market Share by Manufacturer in 2016
Figure Global Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Table Global Hyperimmune Globulins Revenue by Manufacturer (2016-2017)
Figure Global Hyperimmune Globulins Revenue Market Share by Manufacturer in 2016
Figure Global Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Figure Top 3 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2017
Figure Global Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Global Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Global Hyperimmune Globulins Sales by Regions (2013-2018)
Table Global Hyperimmune Globulins Sales Market Share by Regions (2013-2018)
Table Global Hyperimmune Globulins Revenue by Regions (2013-2018)
Figure Global Hyperimmune Globulins Revenue Market Share by Regions in 2013
Figure Global Hyperimmune Globulins Revenue Market Share by Regions in 2017
Figure North America Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Europe Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure South America Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure North America Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table North America Hyperimmune Globulins Sales by Countries (2013-2018)
Table North America Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Figure North America Hyperimmune Globulins Sales Market Share by Countries in 2013
Figure North America Hyperimmune Globulins Sales Market Share by Countries in 2017
Table North America Hyperimmune Globulins Revenue by Countries (2013-2018)
Table North America Hyperimmune Globulins Revenue Market Share by Countries (2013-2018)
Figure North America Hyperimmune Globulins Revenue Market Share by Countries in 2013
Figure North America Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure United States Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Canada Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Mexico Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Europe Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Europe Hyperimmune Globulins Sales by Countries (2013-2018)
Table Europe Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Table Europe Hyperimmune Globulins Revenue by Countries (2013-2018)
Table Europe Hyperimmune Globulins Revenue Market Share by Countries in 2013
Table Europe Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure Germany Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure UK Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure France Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Russia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Italy Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales by Countries (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales Market Share by Countries 2017
Table Asia-Pacific Hyperimmune Globulins Revenue by Countries (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Revenue Market Share by Countries 2017
Figure China Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Japan Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Korea Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure India Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure South America Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table South America Hyperimmune Globulins Sales by Countries (2013-2018)
Table South America Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Figure South America Hyperimmune Globulins Sales Market Share by Countries in 2017
Table South America Hyperimmune Globulins Revenue by Countries (2013-2018)
Table South America Hyperimmune Globulins Revenue Market Share by Countries (2013-2018)
Figure South America Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure Brazil Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Argentina Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Colombia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales by Countries (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Sales Market Share by Countries in 2017
Table Middle East and Africa Hyperimmune Globulins Revenue by Countries (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries in 2013
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure UAE Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Egypt Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Nigeria Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure South Africa Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Table Global Hyperimmune Globulins Sales by Type (2013-2018)
Table Global Hyperimmune Globulins Sales Market Share by Type (2013-2018)
Table Global Hyperimmune Globulins Revenue by Type (2013-2018)
Table Global Hyperimmune Globulins Revenue Market Share by Type (2013-2018)
Figure Global Hepatitis B Immunoglobulins Sales Growth (2013-2018)
Figure Global Hepatitis B Immunoglobulins Price (2013-2018)
Figure Global Rabies Immunoglobulins Sales Growth (2013-2018)
Figure Global Rabies Immunoglobulins Price (2013-2018)
Figure Global Tetanus Immunoglobulins Sales Growth (2013-2018)
Figure Global Tetanus Immunoglobulins Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Hyperimmune Globulins Sales by Application (2013-2018)
Table Global Hyperimmune Globulins Sales Market Share by Application (2013-2018)
Figure Global Government Institutions Sales Growth (2013-2018)
Figure Global Private Sector Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2018-2023)
Table Global Hyperimmune Globulins Sales Forecast by Regions (2018-2023)
Table Global Hyperimmune Globulins Market Share Forecast by Regions (2018-2023)
Figure North America Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure Europe Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure Asia-Pacific Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure South America Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure Middle East and Africa Sales Hyperimmune Globulins Market Forecast (2018-2023)
Table Global Hyperimmune Globulins Sales Forecast by Type (2018-2023)
Table Global Hyperimmune Globulins Market Share Forecast by Type (2018-2023)
Table Global Hyperimmune Globulins Sales Forecast by Application (2018-2023)
Table Global Hyperimmune Globulins Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の超免疫グロブリン市場:メーカー別、地域別、種類別、用途別、市場予測(Global Hyperimmune Globulins Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆